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Bovine tuberculosis, caused by infection with Mycobacterium bovis, is a major endemic
disease affecting cattle populations worldwide, despite the implementation of strin-
gent surveillance and control programs in many countries. The development of high-
throughput functional genomics technologies, including gene expression microarrays and
RNA-sequencing (RNA-seq), has enabled detailed analysis of the host transcriptome to M.
bovis infection, particularly at the macrophage and peripheral blood level. In the present
study, we have analyzed the peripheral blood leukocyte (PBL) transcriptome of eight
natural M. bovis-infected and eight age- and sex-matched non-infected control Holstein-
Friesian animals using RNA-seq. In addition, we compared gene expression profiles gen-
erated using RNA-seq with those previously generated using the high-density Affymetrix®
GeneChip® Bovine Genome Array platform from the same PBL-extracted RNA. A total
of 3,250 differentially expressed (DE) annotated genes were detected in the M. bovis-
infected samples relative to the controls (adjusted P -value ≤0.05), with the number of
genes displaying decreased relative expression (1,671) exceeding those with increased
relative expression (1,579). Ingenuity® Systems Pathway Analysis (IPA) of all DE genes
revealed enrichment for genes with immune function. Notably, transcriptional suppression
was observed among several of the top-ranking canonical pathways including Leuko-
cyte Extravasation Signaling. Comparative platform analysis demonstrated that RNA-seq
detected a larger number of annotated DE genes (3,250) relative to the microarray (1,398),
of which 917 genes were common to both technologies and displayed the same direction
of expression. Finally, we show that RNA-seq had an increased dynamic range compared
to the microarray for estimating differential gene expression.
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INTRODUCTION
Bovine tuberculosis (BTB) is caused by infection with Mycobac-
terium bovis, a member of the Mycobacterium tuberculosis complex
(MTC). The mycobacterial species and strains that constitute the
MTC can cause tuberculosis in a wide range of mammals and
display 99.9% similarity at the nucleotide level (1). Econometric
analyses incorporating agricultural production and human health
indices have placed BTB as the fourth most important disease of
cattle, costing an estimated $3 billion on a global scale annually (2).
Furthermore, as a zoonotic agent, M. bovis infection has important
implications for human health (3, 4).
Mycobacterium bovis is normally transmitted via the inhalation
of infectious bacilli, whereby infection is established in the lung.
Evasion of host immune defenses enables the pathogen to survive
and replicate within phagocytic macrophages, the primary innate
immune cell that mediates the response to infection, and can
result in dissemination of infection via the lymph system leading
to disease progression and pathology (5). Subsequent transmis-
sion of the pathogen to susceptible hosts maintains the cycle of
infection. The immune response to BTB is complex and is largely
characterized by macrophage-mediated development of protective
TH1-type responses following initial exposure to the pathogen. It
has been reported that the development of disease involves a tran-
sition from TH1 to non-protective TH2-type responses (6). The
progression of infection may also be due to the modulation and
suppression of specific immune mechanisms by the pathogen (5).
In many developed countries, control and eradication pro-
grams have been put in place to facilitate early detection and
removal of infected animals. In Ireland, the test and slaughter pol-
icy was introduced in the early 1950s as part of the national BTB
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eradication scheme (7). This policy includes mandatory screening
of animals in the national herd using the single intradermal com-
parative tuberculin test (SICTT), alone or in combination with
in vitro ELISA-based interferon-gamma (IFN-γ) release assays in
infected herds, to increase the sensitivity of diagnosis (8). However,
due to limitations in both of these tests and also the presence of
wildlife reservoirs (including the Eurasian badger, Meles meles) M.
bovis has remained recalcitrant to eradication (6). Consequently,
there is a pressing need to develop novel diagnostics for early and
reliable detection of M. bovis infection in cattle herds.
The availability of a well-annotated bovine genome sequence
with concomitant advances in high-throughput genomics tech-
nologies offers novel approaches to interrogate and better under-
stand the immune response to M. bovis infection. Many tran-
scriptomics studies of the host response to M. bovis have involved
the analysis of blood-derived RNA from naturally or experimen-
tally infected animals, as previous work has shown that for BTB,
host immune responses occurring in peripheral blood reflect
those at the primary site of disease (9). Microarray analysis of
peripheral blood-derived RNA has shown that transcriptional pro-
filing can unambiguously differentiate animals by disease status
and can identify immunomodulatory mechanisms associated with
pathology (10–13).
The advent of high-throughput sequencing technologies has
given rise to new methods for gene expression analysis based on
RNA-sequencing (RNA-seq). This RNA-seq approach has a num-
ber of important advantages compared to microarray analysis,
including unbiased whole-transcriptome profiling; the character-
ization and analysis of both sense and antisense transcription and
novel transcripts; the identification of mRNA isoforms; increased
precision and sensitivity for the quantification of lowly expressed
transcripts; and the detection of expressed coding and regulatory
DNA sequence variants that can influence phenotype [e.g., disease
resistance and susceptibility] (14–16).
To gain a deeper knowledge of the host transcriptional response
to M. bovis infection, we have used RNA-seq to compare the
peripheral blood leukocyte (PBL) transcriptomes of eight animals
naturally infected with M. bovis and eight non-infected control
animals. Differentially expressed (DE) genes identified from this
analysis were further investigated using the Ingenuity® Systems
Pathway Analysis (IPA) Knowledgebase to detect overrepresented
cellular pathways in response to M. bovis infection. We also com-
pared the gene expression profiles generated from RNA-seq with
data from the Affymetrix® GeneChip® Bovine Genome Array
using the same PBL-extracted RNA samples (12).
MATERIALS AND METHODS
ANIMALS
The 16 age-matched female Holstein-Friesian animals used in this
study have been previously described (12). The eight M. bovis-
infected cattle were selected from a panel of naturally infected
animals identified during routine disease surveillance by the Irish
Department of Agriculture, Food and the Marine. These animals
had a positive result for both SICTT and whole blood IFN-γ-
based BOVIGAM® assay tests (Prionics AG, Zurich, Switzerland).
In addition, M. bovis infection was confirmed following detailed
post-mortem pathological examination and culture. Non-infected
control animals were selected from a herd with no recent history
of M. bovis infection and were shown to be negative for both the
SICTT and IFN-γ tests. All animal procedures detailed were per-
formed according to the provisions of the Cruelty to Animals Act
(licenses issued by the Irish Department of Health and Children)
and ethics approval for the study was obtained from the UCD
Animal Ethics Committee.
BLOOD COLLECTION AND RNA EXTRACTION
The materials and methods used to isolate and purify PBL-derived
RNA from all 16 animals have been described by us previously.
Briefly, whole blood was collected from each animal in 8 ml
heparin vacutainers® (Becton-Dickinson Ltd., Dublin, Ireland)
and RNA extraction was performed within 2 h of blood collection.
The complete methods used for blood collection, PBL isolation,
and total RNA extraction and purification have been described by
us previously (12). RNA quantity and quality checking was per-
formed using the NanoDrop™ 1000 spectrophotometer (Thermo
Fisher Scientific, Waltham, MA, USA) and the Agilent 2100 Bioan-
alyzer using an RNA 6000 Nano LabChip kit (Agilent Technologies,
Cork, Ireland). All samples displayed a 260/280 ratio >1.8 and RNA
integrity numbers (RIN) >8.0.
RNA-seq LIBRARY PREPARATION
The laboratory method used to generate RNA-seq libraries was
adapted from a protocol previously described by our group (17).
In total, 16 strand-specific RNA-seq Illumina® libraries were pre-
pared (i.e., eight libraries each for the infected and control groups)
using 1.2µg of total RNA. Total RNA was heated at 65°C for 5 min
to disrupt any secondary structure and purification of poly(A)
RNA was performed using a Dynabeads® mRNA DIRECT® Micro
Kit according to the manufacturer’s instructions (Invitrogen™).
Purified poly(A) RNA was then fragmented using 1× RNA Frag-
mentation Reagent (Ambion®/Life Technologies Ltd.,Warrington,
UK) for 5 min at 70°C and precipitated using 68 mM sodium
acetate pH 5.2 (Ambion®), 227 ng/µl glycogen (Ambion®), and
30µl of 100% ethanol (Sigma-Aldrich Ltd., Dublin, Ireland).
Pellets were washed with 80% ethanol, air-dried for 10 min at
room temperature, and re-suspended in 10.5µl DNase- and
RNase-free water.
Synthesis of first strand cDNA was performed by incubat-
ing fragmented RNA with 261 mM Random Hexamer Primers
(Invitrogen™), 1× first strand buffer (Invitrogen™); 10 mM DTT
(Invitrogen™); 0.5 mM dNTPs; 20 U RNaseOUT™ recombi-
nant ribonuclease inhibitor; and 200 U SuperScript® II Reverse
Transcriptase (Invitrogen™) at 25°C for 10 min, at 42°C for
50 min, and 70°C for 15 min. First strand synthesis reaction
mixtures were purified using MicroSpin G-50 columns accord-
ing to the manufacturer’s instructions (GE Healthcare UK Ltd.,
Buckinghamshire, UK).
Second strand cDNA synthesis, involving the incorporation of
uracil, was performed by adding the first strand cDNA synthesis
reaction to a second strand reaction mix consisting of 0.065× first
strand buffer (Invitrogen™); 1× second strand buffer (Invitro-
gen™); a dNTP mix consisting of a final concentration of 0.3 mM
dATP, dCTP, dGTP (Sigma-Aldrich) and 0.3 mM dUTP (Bioline
Reagents Ltd.,London,UK); 1 mM DTT (Invitrogen™); 2 U RNase
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H (Invitrogen™) and 50 U E. coli DNA Polymerase I (Invitro-
gen™). Reactions were incubated at 16°C for 2.5 h. The dou-
ble stranded cDNA was subsequently purified using a QIAquick
PCR Purification kit (Qiagen) according to the manufacturer’s
instructions and eluted in 30µl of the provided elution buffer.
Blunt-end repair of cDNA was performed in a 100µl reac-
tion containing 1× T4 DNA ligase buffer with 10 mM dATP
(New England Biolabs® Inc., Ipswich, MA, USA), 0.4 mM of each
dNTP (Invitrogen™), 15 U T4 DNA polymerase (New England
Biolabs®), 5 U DNA Polymerase I Large [Klenow] Fragment (New
England Biolabs®), and 50 U T4 polynucleotide kinase (New Eng-
land Biolabs®). Reactions were incubated at 20°C for 30 min and
the cDNA was then purified using a QIAquick PCR Purification Kit
(Qiagen) according to the manufacturer’s instructions and eluted
in 32µl of the provided elution buffer.
To facilitate Illumina® GA adaptor ligation, a single “A” base
was added to the 3′ ends of the blunt-end-repaired cDNA sam-
ples. Thirty-two microliters of purified phosphorylated blunt-
end-repaired cDNA was included in a final 50µl reaction mixture
containing 1× Klenow fragment buffer (New England Biolabs®);
0.2 mM dATP (Invitrogen™), and 15 U Klenow fragment with 3′-
to-5′ exonuclease activity (New England Biolabs®). Reactions were
incubated at 37°C for 30 min, after which cDNA was purified using
a QIAquick MinElute Kit (Qiagen) according to the manufac-
turer’s instructions and eluted in 21µl of the provided elution
buffer.
Illumina® RNA-seq adaptor ligation reactions (50µl volumes)
involved incubation of 21µl of phosphorylated blunt-ended
cDNA containing a 3′-dATP overhang with 1×Quick DNA ligase
buffer (New England Biolabs®); 30 nM custom indexed single-
read adaptors (see Table S1 in Supplementary Material for barcode
index sequences); and 15 U T4 DNA ligase (Invitrogen™). Reac-
tion mixes were incubated at room temperature for 15 min and
purified using a QIAquick MinElute Kit according to the manu-
facturer’s instructions (Qiagen) and eluted in 10µl of the provided
elution buffer. Adaptor-ligated cDNA was gel-purified using 2.5%
agarose gels stained with 1× SYBR® Safe DNA gel stain (Invitro-
gen™). Gels were electrophoresed at 100 V using 1× TAE buffer
(Invitrogen™) for 75 min at room temperature. Size fractionated
bands corresponding to 200 bp (+50 bp) were excised from each
sample and purified using a QIAquick Gel Extraction kit (Qiagen)
according to the manufacturer’s instructions and eluted in 30µl of
elution buffer. To generate strand-specific RNA-seq libraries, the
second strand of the gel-purified adapter-ligated cDNA containing
uracil was digested enzymatically in 30µl reaction volumes con-
taining 1× Uracil-DNA Glycosylase buffer and 1 U Uracil-DNA
Glycosylase (Bioline). Reactions were incubated at 37°C for 15 min
followed by 94°C for 10 min.
PCR enrichment amplifications (25µl) were performed and
contained 9µl of second strand-digested, adaptor-ligated cDNA;
1× Phusion® High-Fidelity DNA polymerase buffer (New Eng-
land Biolabs®); 334 nM each Illumina® PCR primer (Illumina®
Inc., San Diego, CA, USA); 0.4 mM each of dATP, dCTP, DGTP,
and dTTP (Invitrogen™) and 1 U Phusion® High-Fidelity DNA
polymerase (New England Biolabs®). PCR amplification reactions
consisted of an initial denaturation step of 98°C for 30 s, 18 cycles
of 98°C for 10 s, 65°C for 30 s, and 72°C for 30 s, followed by a final
extension step of 72°C for 5 min. PCR products were visualized
following electrophoresis on a 2% agarose gel stained with 0.25×
SYBR® Safe DNA gel stain (Invitrogen™) and purified to remove
PCR-generated adaptor-dimer using an Agencourt AMPure XP
kit (Beckman Coulter Genomics, Danvers, MA, USA) according
to the manufacturer’s instructions with final elution in 30µl of
1× TE buffer.
All RNA-seq libraries were quantified using a Qubit® Fluorom-
eter (Invitrogen™). RNA-seq library quality was assessed using an
Agilent Bioanalyzer and Agilent High sensitivity DNA chip (Agi-
lent) and confirmed that library insert sizes were ~200–250 bp for
all individual libraries. Individual RNA-seq libraries were stan-
dardized and pooled in equimolar quantities (10µM for each
individual library). The quantity and quality of the final pooled
library was assessed as described above prior to sequencing.
The libraries were subsequently validated using conventional
Sanger sequencing of individual library clones. Library frag-
ments from two libraries were cloned using the Zero Blunt®
TOPO® PCR Cloning system according to the manufacturer’s
instructions (Invitrogen™). Conventional Sanger sequencing of
10 plasmid inserts from each of the 2 libraries confirmed that
the RNA-seq libraries contained inserts derived from bovine
mRNA. Plasmid sequencing was outsourced (Source Bioscience
Ltd., Dublin, Ireland) and sequences generated were validated
using BLAST-searching of the DNA sequence database (18).
Cluster generation and sequencing of the pooled RNA-seq
library was performed on an Illumina® Cluster Station and
Genome Analyzer IIx sequencer according to the manufacturer’s
instructions. The pooled library was sequenced as single-end read
84-mers using Illumina® version 4.0 sequencing kits and the stan-
dard Illumina® Genome Analyzer IIx pipeline. The Illumina®
Sequencing Control Software version 2.9 and Real-Time Analysis
version 1.9 software packages were used for real-time tracking of
the sequencing run, real-time image processing, the generation of
base intensity values, and base calling. These RNA-seq data have
been deposited in the NCBI Gene Expression Omnibus (GEO)
database with experiment series accession number GSE60265.
BIOINFORMATICS AND STATISTICAL ANALYSIS OF RNA-SEQ AND
MICROARRAY DATA
All the bioinformatics pipeline bash, Perl, and R scripts used for
computational analyses were deposited in a GitHub repository
at https://github.com/kmcloughlin1 and these analyses were per-
formed on a 32-node Compute Server running Linux Ubuntu
(version 12.04.2).
An initial quality check was performed on each of the raw
read data files using the FastQC software (version 0.10.1)1 to
determine the best sequence read quality filtering strategy. Sub-
sequently, a custom perl script was used to: (1), deconvolute the
pooled libraries into individual libraries of sample sequence reads
based on the unique index barcode (allowing up to one mismatch
as long as the barcode sequence can be associated to a single unique
index barcode); (2) filter out single-end reads containing adap-
tor sequence (allowing up to three mismatches); and (3) remove
1http://www.bioinformatics.babraham.ac.uk/projects/fastqc
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single-end reads of poor quality (i.e., reads containing 25% of
bases with a Phred quality score below 20). Filtered individual
libraries file were checked again with the FastQC software pack-
age to confirm sequence read quality. Single-end reads, from each
filtered individual sample library, were aligned to the Bos tau-
rus reference genome [UMD3.1.73; (19)] using the STAR aligner
software package [version 2.3.0] (20).
For each library, raw counts for each annotated gene were
obtained using the featureCounts software from the Subread pack-
age [version 1.3.5-p4] (21). The featureCounts parameters were
set to unambiguously assign uniquely aligned single-end reads in
a stranded manner to the exons of genes within the B. taurus
reference genome annotation (UMD3.1.73 genome annotation).
Differential gene expression analysis was performed using the
gene raw counts, obtained from featureCounts, within the Bio-
conductor edgeR package (22). The differential gene expression
pipeline within the edgeR package was customized to (1) filter out
all bovine rRNA genes; (2) filter out genes displaying expression
levels below the minimally set threshold of one count per mil-
lion (CPM) in at least eight individual libraries (i.e., equivalent
to one group of biological replicates); (3) calculate normaliza-
tion factors for each library using the trimmed mean of M -values
method (14); (4) generate the density of counts per gene and
multidimensional scaling (MDS) plots based on data from each
individually barcoded library (using the Euclidean distance met-
ric); (5) estimate the dispersion parameter for each library using
the Cox-Reid method; (6) identify DE genes between infected ver-
sus non-infected control samples (i.e., unpaired-sample statistical
model) using a negative binomial generalized linear model; and
(7) adjust the P-value for multiple testing using the Benjamini–
Hochberg correction (23) with a false discovery rate (FDR)≤0.05.
Mean fold-changes in gene expression are reported in the main
body text as geometric mean values in the M. bovis-infected group
relative to the control group; for genes displaying reduced relative
expression, the negative reciprocal geometric mean fold-changes
are given.
The IPA® Knowledgebase2 was used to identify cellular path-
ways and gene ontology categories that were overrepresented based
on the list of DE genes (P-value ≤0.05).
The raw microarray data generated from the same 16 PBL-
extracted RNA samples were retrieved from the NCBI GEO
repository (24) with the accession number GSE33359 (12). The
Affymetrix® GeneChip® Bovine Genome Array used to gener-
ate these data contains 24,072 probe sets representing more than
23,000 gene transcripts. To compare gene expression profiles
from these samples using RNA-seq and the microarray, we first
re-analyzed the microarray data using a series of Bioconductor
packages (25) and the most recent build of the bovine genome
[UMD3.1.73; (19)]. Normalization of raw data was performed
using the Factor Analysis for Robust Microarray Summarization
(FARMS) algorithm (26). The FARMS algorithm uses only per-
fect match (PM) probes and a quantile normalization procedure,
providing both P-values and signal intensities. Normalized data
were then further subjected to filtering for informative probes
2http://www.ingenuity.com
sets using the informative/non-informative (I/NI) calls unsuper-
vised feature selection criterion implemented in FARMS (27).
This defines a probe set as being informative when many of its
probes reflect the same change in mRNA concentration across
arrays. To compare and contrast the two gene expression tech-
nologies, microarray probe sets were first annotated with the
corresponding Ensembl ID using the Bioconductor biomaRt pack-
age (28). Genes displaying differential expression between control
and infected groups were identified using the linear models for
microarray data (LIMMA) bioconductor package (29). Following
this, a Benjamini–Hochberg multiple-testing correction of ≤0.05
was applied to all DE genes (23) and the Euclidean distance was
used as the distance metric for MDS plotting.
RESULTS
SUMMARY STATISTICS FOR THE RNA-seq DATA
All 16 RNA-seq libraries were sequenced across one full Illumi-
na® GAIIX flow cell. Deconvolution and filtering of sequence
reads to remove adaptor-dimer contamination yielded a mean
of 13.2 million reads per individual barcoded RNA-seq sample
library. Alignment of the filtered reads to the B. taurus UMD3.1.73
genome build yielded a mean of 11.8 million reads (90%) that
aligned to unique locations in the bovine genome for each RNA-
seq library; a mean of 906,679 reads (7%) for each library that
aligned to multiple locations in the genome; and a mean of 381,991
reads (3%) for each library that did not align to any genome loca-
tion (Table S1 in Supplementary Material). Further analysis of
the mean 11.8 million reads mapping to unique genome loca-
tions demonstrated that 52% of these mean reads were assigned to
annotated regions of the genome, which were used to calculate raw
counts for each sense gene and subsequently used for downstream
bioinformatics and systems analyses; while 48% were not assigned
to any annotated genome location or were assigned to overlapping
(therefore ambiguous) annotated genomic regions.
GENE EXPRESSION AND IPA ANALYSIS OF SENSE STRAND
TRANSCRIPTION
Analysis of the gene coverage based exclusively on sense strand
sequence information, revealed that of the 24,616 annotated B.
taurus genes in Ensembl (release 73), 17,792 genes (72.3%) had
at least one sequence read count (i.e., one mapped read) in at
least 1 of the 16 individual sample RNA-seq libraries. The 17,792
detectable genes were further filtered by removing lowly expressed
genes, whereby only genes displaying more than 1 CPM reads in
8 or more individual libraries were used for subsequent analyses.
This yielded 12,294 genes (49.9% of annotated B. taurus genes)
that were suitable for downstream analyses.
Prior to differential gene expression analysis, the 12,294 fil-
tered genes were used to generate an MDS plot to visualize gene
expression and infection status for the 16 animal PBL samples
(Figure 1A). This plot shows that samples were clearly differ-
entiated according to infection status along dimension 1 and
dimension 2 highlights one M. bovis-infected sample as a possible
outlier (Infected 34 – animal ID).
Statistical analysis of all 12,294 genes that passed the filtering
process identified a total of 3,250 DE genes (FDR≤0.05), of which
1,579 and 1,671 displayed increased and decreased expression,
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FIGURE 1 | Multidimensional scaling plot of M. bovis-infected and
control samples based on RNA-seq sense data and microarray data.
(A) MDS plot of 8 M. bovis-infected and 8 control PBL samples generated
from 12,294 genes that passed all data filtering prior to differential gene
expression (based on RNA-seq sense data only). (B) MDS plot using data
from 5,082 informative microarray probe sets in 8 M. bovis-infected and 8
control PBL samples.
respectively, in the M. bovis-infected samples relative to the non-
infected control samples (Table S2 in Supplementary Material).
Among the DE genes showing the greatest mean fold-change
increase in expression were CXCL6 (+6.77), IL8 (+5.39), and
CTLA4 (+3.61), while CXCL10 (−3.27), DEFB10 (−7.21), and
IL12 (−4.35) showed the greatest mean fold-change decrease
in expression; all of these genes have been previously shown to
be involved in the host response to mycobacterial infection (12,
30–33).
Functional categorization of the DE genes using IPA revealed an
overrepresentation of genes with roles in inflammatory response,
immunological disease and infectious disease. Of the 3,250 genes
found to be DE, 2,785 mapped to the IPA Knowledgebase. IPA
analysis identified 201 statistically significant (P-value ≤0.05)
enriched pathways, many of which were associated with immune
function (Table S3 in Supplementary Material). Based on the
well-documented role of the T-cell response to mycobacterial
infection, the top-ranking IPA canonical pathway (T-cell recep-
tor signaling ) was overlaid with the RNA-seq gene expression
data, which indicated activation of this pathway (Figure 2). Fur-
ther inspection of the IPA results showed Leukocyte extravasation
signaling to be the second-ranked canonical pathway. Transcrip-
tional suppression was observed for this pathway with several
genes required for migration of leukocytes to the site of infec-
tion displaying reduced relative expression (Figure 3). These
include genes encoding leukocyte ligands required for endothe-
lial adhesion such as ITGB2 (−1.29-fold), ITGAL (−1.23-fold),
and SPN (also known as CD43; −1.42-fold). Reduced relative
expression of the gene encoding the LFA-1 protein was also indi-
rectly observed in these BTB-infected animals. LFA-1 is a com-
plex formed from an α-chain encoded by ITGAL and a β-chain
encoded by ITGB2; both ITGAL and ITGB2 exhibited decreased
relative expression as discussed above. Decreased relative expres-
sion of PECAM1 (−1.69-fold), which encodes a protein involved
in the transmigration of leukocytes through or between endothe-
lial layers into tissues during extravasation, was also detected
in the present study (34). Furthermore, a reduction in rela-
tive expression was also observed for MMP9 (−1.79), which
degrades the extracellular matrix facilitating the transmigration
of leukocytes (35, 36).
COMPARISON OF THE NUMBER OF DIFFERENTIALLY EXPRESSED
GENES IDENTIFIED FROM RNA-seq AND MICROARRAY PLATFORMS
The RNA extracted from these animals has previously been ana-
lyzed using the Affymetrix® Bovine Genome Array (12). To directly
compare gene expression profiles generated by the two platforms,
we re-analyzed all microarray data and of the 24,072 probe sets
represented on the microarray, 5,082 of these passed the filter-
ing process and were designated as informative. An MDS plot
generated from these 5,082 informative probe sets shows samples
clustered according to their infection status (Figure 1B); this pat-
tern was also observed for these samples by Killick and colleagues
using hierarchical clustering (12).
Analysis of all informative microarray probe sets identified
2,808 DE transcripts (FDR ≤0.05) and mapping of these tran-
scripts to the B. taurus UMD3.1.73 genome build yielded 1,398
DE genes with Ensembl IDs (Table S4 in Supplementary Mater-
ial). This is substantially lower than the 2,757 DE genes previously
reported by us for the same RNA samples (12). This discrep-
ancy may be explained by differences in the versions of the B.
taurus reference genome used to annotate the microarray probe
sets: for the previous study, we used the Btau4.0 genome assem-
bly, while in the current study the UMD3.1.73 genome assembly
was used. Discrepancies between the two genome annotations
as detailed by Zimin et al. (37) most readily account for the
reduced number of DE genes with Ensembl IDs observed for the
present study.
Of the 1,398 DE genes obtained from re-analysis of the
Affymetrix® Bovine Genome Array in infected animals relative
to the control animals, 630 and 768 exhibited increased and
decreased expression, respectively. Consequently, it is notewor-
thy that the number of Ensembl-annotated DE genes obtained
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FIGURE 2 |The top-ranked enriched canonical pathway identified
using IPA, theT-cell receptor signaling pathway. Red shading
indicates increased expression in M. bovis-infected animals relative to
the non-infected control group. Green shading indicates decreased
expression in M. bovis-infected animals relative to the non-infected
control group.
with the RNA-seq analysis (3,250 DE genes; 1,579 increased rel-
ative expression and 1,671 decreased relative expression) was
markedly higher than the number of DE genes detected using
the microarray. Further examination of the results showed that
917 DE Ensembl genes had the same direction of expression (i.e.,
increased or decreased relative expression) on both platforms;
2,331 DE Ensembl genes were unique to the RNA-seq results (i.e.,
DE using RNA-seq but not DE on the microarray platform); and
479 DE Ensembl genes were unique to the microarray (i.e., DE
on the microarray platform but not DE on the RNA-seq plat-
form). Finally, two of the genes were found to have conflicting
patterns of expression, i.e., genes that displayed increased relative
expression on one platform and decreased relative expression on
the other platform. CHTOP showed decreased relative expression
on the RNA-seq platform but increased relative expression on the
microarray platform and GPR89 showed increased relative expres-
sion on the RNA-seq platform but decreased relative expression
on the microarray platform (Figure 4).
Finally, analysis and comparison of the number of IPA-
identified statistically significant canonical pathways (P-value
≤0.05) for the DE genes from both platforms revealed 101 path-
ways that were common to both, 100 that were unique to RNA-seq,
and 36 that were unique to the microarray. The larger number
of IPA-identified canonical pathways from the RNA-seq results
reflects the greater number of DE genes detected using this plat-
form. Despite this, however, there was a notable level of overlap in
the number of pathways identified using both platforms. The per-
centage of overlapping pathways between the two platforms was
estimated as 50.2% for RNA-seq and 73.7% for the microarray
(Tables S3 and S5 in Supplementary Material).
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FIGURE 3 |The second-ranked enriched canonical pathway
identified using IPA, the Leukocyte extravasation pathway. Red
shading indicates increased expression in M. bovis-infected animals
relative to the non-infected control group. Green shading indicates
decreased expression in M. bovis-infected animals relative to the
non-infected control group.
FIGURE 4 | Venn diagram showing comparison of differentially
expressed genes identified from sense RNA-seq data and the
microarray. Sets of upregulated genes are represented in red and sets of
downregulated genes are in green.
CORRELATION OF THE LOG FOLD-CHANGE IN GENE EXPRESSION
BETWEEN THE TWO PLATFORMS USING ALL GENES THAT PASSED
FILTERING
We analyzed the correlation between the log2 fold-changes
(infected versus control) on both gene expression platforms. We
hypothesized that genes with high differential fold-changes in
expression based on RNA-seq analysis should also show high
differential fold-changes based on the microarray data. Accord-
ingly, these data would be expected to yield a significant, positive
correlation. For this, all 12,294 genes and 5,082 probe sets that
passed the filtering criteria across both sample groups for both
RNA-seq and microarray analysis, respectively, were considered.
Next, we identified all the genes, irrespective of significance, that
were common to both data sets based on Ensembl gene ID, this
involved matching the Ensembl IDs of the filtered genes in the
RNA-seq data set with the Ensembl IDs of the filtered microarray
probe sets. In total, 2,265 Ensembl IDs were identified in com-
mon between the two platforms. The log2 fold-change values for
these 2,265 genes (infected versus control) for both the RNA-seq
and microarray data, irrespective of the significance of differential
expression generated a Spearman correlation coefficient of 0.88
(P ≥ 0.001), which underlines the reproducibility and robustness
of both platforms for investigations of differential gene expression.
COMPARISON OF THE FOLD-CHANGE AND DIFFERENCE IN
EXPRESSION VALUES FOR RNA-seq AND MICROARRAY DATA
We next investigated the correlation between fold-change in
expression and gene expression levels. This enabled us to deter-
mine if the highest fold-changes in gene expression were observed
for genes with low levels of expression. For this, we compared
the log2 expression fold-changes with the log2 differences in CPM
between infected and control groups for the RNA-seq platform.
We also compared the log2 expression fold-changes with the log2
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differences in hybridization intensity between infected and con-
trol groups for the microarray platform. We hypothesized that if
transcripts with the lowest expression levels gave the highest fold-
change values, a negative correlation would be observed between
log2 expression fold-changes and log2 differences for genes dis-
playing increased relative expression in the infected group relative
to the control group. Reciprocally, a positive correlation would
be expected between log2 expression fold-changes and log2 dif-
ferences for genes displaying decreased relative expression for the
same group contrast.
For the RNA-seq platform, all 12,294 genes that passed filter-
ing were used. Of these, 6,243 displayed an increase in relative
expression and 6,051 displayed a decrease in relative expression,
irrespective of significance. Spearman rank correlation coefficients
of 0.35 and −0.43 were observed for genes displaying increased
and decreased relative expression, respectively (P ≤ 0.001). For
the microarray platform, we used all 5,082 probe sets that passed
filtering of which 2,551 displayed an increase in expression and
2,531 displayed a decrease in expression, irrespective of signifi-
cance. Spearman rank correlation coefficients of 0.61 and −0.64
were observed for genes displaying increased and decreased rel-
ative expression, respectively (P ≤ 0.001). The correlation coeffi-
cients for both the RNA-seq and microarray platforms for genes
with increased and decreased relative expression do not support
the hypothesis detailed above; therefore, we conclude that there
is no obvious relationship between gene expression level and
fold-change in expression.
DYNAMIC RANGE OF RNA-seq AND MICROARRAY DATA
To investigate the dynamic range of the RNA-seq and microarray
platforms, the log2 reads per kilobase per million (RPKM) from
the RNA-seq data and the log2 intensities from the microarray data
were used; only genes and probe sets that passed the filtering crite-
ria (12,294 and 5,082, respectively) were considered for this analy-
sis. The lowest expression value was subtracted from the highest
expression value for each platform. For the RNA-seq platform,
the gene displaying the lowest expression level was MUC5B (log2
RPKM of −6.49), while the gene with the highest value was COX1
(log2 RPKM of 13.46); this yielded a log2 dynamic range of 19.96.
It is important to note that as RPKM values are proportions, val-
ues <1.0 will yield a negative result when log-transformed. For the
microarray platform, the probe set with the lowest log2 intensity
was Bt.29403.1.s1_at (4.89) and the probeset with the highest log2
intensity was AFFX-Crex-5_at (13.90), yielding a log2 dynamic
range of 9.01. Therefore, the dynamic range of RNA-seq for the
current study is almost 2,000-fold greater than the microarray.
DISCUSSION
Whole-genome transcriptional profiling has been successfully
used to study human and BTB and has facilitated high-resolution
analysis of the host genes and cellular pathways that are activated
and perturbed in response to mycobacterial pathogens (11–13,
17, 38–42). The target tissue for studies of the host response has
generally been peripheral blood collected from infected and non-
infected individuals or animals; peripheral blood provides an easily
accessible biological sample that reflects the host immunological
and pathological changes induced at the site of infection (9). For
example, Berry and colleagues identified a microarray-derived 393
transcript biomarker signature, characterized by type 1 interferon-
inducible genes, which discriminated active human TB patients
from latently infected and healthy control individuals (38). Fur-
thermore, microarray-based comparative analysis of the periph-
eral blood transcriptome of active human tuberculosis cases and
sarcoidosis patients (an analogous granulomatous disease of the
respiratory tract of unknown etiology) also revealed a transcrip-
tional signature that differentiated these two pathologically similar
diseases (39). Similarly for BTB, pan-genomic and immuno-
specific microarray analysis of peripheral blood has demonstrated
that M. bovis-infected and non-infected animals can be unam-
biguously differentiated by disease status. Moreover, downstream
analysis of the DE genes provided functional genomics evidence
that active BTB is associated with the suppression of host innate
immune responses and impairment of T-cell signaling (10, 12).
Notwithstanding the remarkable progress in functional
genomics studies of the immunobiology and host–pathogen inter-
actions, microarray studies of the host response to mycobacterial
infections are not without limitations. For example, microarrays
are limited to analysis of genes/transcripts for which probes can be
generated from functionally annotated genome resources. In addi-
tion, quantification of gene expression indirectly from hybridiza-
tion signal intensities constrains the dynamic range for lowly
and highly expressed gene transcripts. Also, the measurement of
gene expression can be hampered by probes that differ in their
hybridization affinities with the target mRNA and by background
non-specific hybridization, particularly for lowly expressed genes
(15, 43, 44).
In contrast, RNA-seq technologies, which are based on high-
throughput sequencing and subsequent counting of all expressed
RNA transcripts present in a biological sample, have several
advantages for quantifying RNA abundance and unraveling the
complexity of the host transcriptome following mycobacterial
infection. These include unbiased global gene expression analy-
sis (the entire transcriptome is normally surveyed), detection of
allele-specific expression, and cataloging of novel transcripts, RNA
classes (e.g., long non-coding RNA transcripts), and splice variants
that are rarely quantifiable using microarray technologies (15, 44).
Also, RNA-seq analysis is based on digital counts of reads that map
to annotated genes within a reference genome, thus offering a more
precise and sensitive method to identify and quantify DE genes
than analog microarray hybridization intensities. Consequently,
for the present study we have compared the peripheral blood tran-
scriptomes of non-infected control animals and animals naturally
infected with M. bovis (eight samples per group) using RNA-seq
and compared these results to parallel data obtained using the
pan-genomic Affymetrix® Bovine Genome Array.
FUNCTIONAL BIOLOGY OF RNA-seq RESULTS
A mean of 13.2 million 78-mer reads per individually barcoded
RNA-seq library was obtained and this yielded a mean of 1.03 Gb
of sequence data per library. A mean of 11.8 million reads (89%
of the mean number of library reads) per library mapped to
unique locations in the bovine UMD3.1 reference genome. This
is higher than previously reported comparable studies: Nalpas
and colleagues observed that 63.6% of reads mapped to unique
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UMD3.1 regions and Churbanov and colleagues observed that
71.2% of reads mapping to the Btau 4.0 reference genome (17,
45). Analysis of the gene coverage from these uniquely mapped
reads revealed that 17,792 genes from a total of 24,616 annotated
bovine genes gave at least 1 sequence read in at least 1 of the 16
individual libraries. As accurate quantification of gene expression
is reliant on sequencing depth, whereby low sequencing cover-
age can lead to the generation of false-positive DE genes (type I
errors) (46, 47), we have used a stringent sequencing-depth fil-
tering criterion to remove lowly expressed genes. This filtering
involved the retention of genes displaying more than one CPM in
eight or more individual libraries; 12,294 genes (49.9% of anno-
tated B. taurus genes) were retained for downstream differential
expression analyses. The number of biological replicates (n= 8)
and mean sequencing depth per library achieved in the present
study is sufficient for the accurate quantification and analysis of
DE genes with a corresponding reduction in the number of type I
errors due to lowly expressed genes (46–48).
Previous work by our group and others has demonstrated that
a functional genomics approach can highlight novel aspects of
the complex etiology of M. bovis infection in cattle. These studies
have confirmed the role of TH1-type cytokines and chemokines
and innate immune receptors (e.g., TLR genes) in mediating the
response to M. bovis infection. Moreover, these investigations sup-
port the hypothesis that the immunoevasive mechanisms used by
the pathogen during infection are reflected in the host transcrip-
tome at the peripheral blood level; in particular, the suppression
of innate immune signaling, which leads to an inferior adaptive
immune response (10, 12).
In the current study, RNA-seq was used to identify a total of
3,250 DE genes in the infected group relative to the control group;
of these, 1,579 genes displayed increased relative expression and
1,671 genes showed reduced relative expression. The number of
DE genes identified here through RNA-seq analysis exceeds the
number of DE gene previously reported by Killick et al. (12) for the
same RNA samples (2,757 DE genes; 1,281 and 1,476 genes display-
ing increased and decreased relative expression, respectively). This
finding emphasizes the increased sensitivity of RNA-seq compared
to microarrays for studies of differential gene expression (17, 49).
Gene ontology analysis revealed enrichment for genes
involved in inflammation and immunity. TH1-type cytokines and
chemokines, such as CXCL6 and IL8, were among the top-ranking
DE genes based on fold-change in expression; additional innate
immune genes, such as CCL4, CXCR4, CXCR7, IL1A, IL8, IL10,
and TLR4 also shown increased expression in the M. bovis-infected
group relative to the controls. Several innate immune genes also
displayed reduced relative expression including CXCL10, DEFB10,
IL12, IL18, and IL27. These results suggest that although innate
immune genes play a role in mediating the host response to
M. bovis infection, these genes may also serve as targets for
immunomodulation by the pathogen to facilitate survival in the
host. For example, IL12, IL18, and IL27 encode cytokines that
have all been shown to play key roles in initiating and control-
ling the adaptive immune response to mycobacterial infection
(31, 50); suppression of these genes may result in the devel-
opment of an inferior cellular response to infection leading to
disease progression. The increased relative expression of the IL10
gene, which encodes an immunosuppressive cytokine, may also
result in the suppression of host innate immune responses to
infection resulting in mycobacterial persistence within the host
(51). Collectively, these findings support our previous work, which
hypothesized that the suppression of innate immune expression
and signaling limits the initiation and maintenance of an appro-
priate adaptive immune response, contributing to the progression
of BTB disease (10, 12).
Further analysis of the DE genes using the IPA Knowledge-
base identified additional cellular mechanisms within several of
the top-ranking canonical pathways, which may be subject to
immunomodulation by the pathogen, including the Leukocyte
Extravasation Signaling and Tec Kinase Signaling pathways. The
Leukocyte Extravasation Signaling pathway exhibited a decrease
in expression for many genes encoding positive modulators of
this pathway, including SPN (also known as CD43), ITGAL,
ITGB2, and PECAM1 (52–55). Leukocyte extravasation refers to
the transendothelial migration of activated leukocytes from the
blood into infected tissue and is vital for immune surveillance
and defense (56). This process, which requires the adherence of
leukocytes to the endothelial surface of blood vessels followed by
transmigration through the endothelial blood vessel cell layer into
the infected tissue, is mediated by chemokines and several cell
surface proteins and adhesion molecules including selectins and
integrins (57). Within the IPA-identified Leukocyte Extravasation
Signaling pathway, transcriptional suppression was observed for
several leukocyte ligands required for endothelial adhesion dur-
ing extravasation. SPN, ITGAL, and ITGB2 encode the CD43 and
the CD11b and CD18 leukocyte cell surface ligands, respectively
[the latter of which can complex with different protein partners
to form different integrins such as LFA-1 and MAC1 (58)], which
are required for leukocyte adhesion to the endothelial cells and
subsequent transmigration of the leukocytes into infected tissue
(54, 59, 60). PECAM1 encodes a selectin protein found at intercel-
lular endothelial junctions and is also required for transmigration
across these barriers (52, 61). Lower expression of these ligands
may result in reduced leukocyte recruitment to the site of infec-
tion, leading to an impaired adaptive immune response to contain
or eradicate M. bovis infection in the host, ultimately leading to
disease progression. In addition, these findings lend further sup-
port to the hypothesis that the immunoevasion mechanisms used
by the pathogen are reflected in the host transcriptome.
Hematological analysis of blood samples taken from the ani-
mals analyzed in the current study showed a significant increase
in the mean number of lymphocytes (P = 0.001) and a significant
decrease in the mean number of monocytes (P = 0.002) for the
infected animals relative to the control group (12). Conversely, no
significant differences were observed in the mean number of neu-
trophils between the two sample groups (P ≥ 0.05). It is therefore
likely that many of the gene expression changes observed in the
current study reflect differences in white blood cell populations
between the sample groups.
WHOLE-GENOME EXPRESSION PROFILING: RNA-seq VERSUS
MICROARRAYS
The PBL-extracted RNA analyzed in the present study using RNA-
seq had also been previously analyzed by us using the Affymetrix®
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GeneChip® Bovine Genome Array (12); this enabled a direct tech-
nical comparison between the two platforms. RNA-seq analysis
detected 2.3-fold (3,250/1,398) more DE genes with Ensembl IDs
compared to the microarray platform. The percentage of over-
lapping DE genes with Ensembl IDs between the two platforms
was estimated at 28.2% for RNA-seq (917/3,250) and 65.6%
(917/1,398) for the microarray. Similarly, the concordance rate
based on IPA-identified canonical pathways for the two platforms
was estimated at 73.7% for the microarray and 50.2% for RNA-seq.
These results demonstrate that the majority of DE genes detected
using the microarray are also detected by RNA-seq. This finding
also highlights the greater number of DE genes uniquely identified
by RNA-seq compared to microarrays as previously reported by
us and others (17, 62, 63).
In the current study, the greater number of DE genes detected
using RNA-seq can be largely attributed to the greater dynamic
range of RNA-seq, which enables sensitive detection of lowly,
but DE genes between the infected and control groups (46, 47).
Notably, the concordance rate for the microarray (65.6%) is higher
than that previously reported by our group for monocyte-derived
macrophages (MDM) infected in vitro with M. bovis (17) and
by (64), who examined the transcriptome of anti-CD3- and anti-
CD28-stimulated human CD4+ T cells. The increased microarray
concordance rate (based on the number of DE genes) observed for
the current study compared to these previous studies is likely due
to increased sequencing depth and a greater number of biological
replicates (46–48).
Interestingly, two DE genes (0.06% of all RNA-seq DE genes
and 0.14% of all microarray DE genes) displayed opposite direc-
tions of expression on the two platforms. These discordance rates
are lower than that previously reported for RNA-seq and microar-
ray analysis of human cancer cell transcriptomes (65) and may
be explained by several technical factors including random error,
differences in the transcript isoforms detected by both platforms,
and the susceptibility of microarray probes to cross-hybridize with
non-specific gene transcripts (66, 67).
WHOLE-GENOME TRANSCRIPTOMICS: BIOMARKER DEVELOPMENT
FORM. BOVIS INFECTION
Multidimensional scaling analysis using all RNA-seq genes that
passed the filtering criteria unambiguously differentiated animals
on the basis of their disease status (Figure 1A). This result is also
supported by the microarray data generated (12) and re-analyzed
here. These findings suggest that genome-wide expression profil-
ing of peripheral blood from M. bovis-infected animals can be
used to identify transcriptional biomarkers for the detection of
infected animals within herds and thereby augment surveillance
strategies in countries where BTB control programs have been
implemented. In addition, recent work has demonstrated that
circulating serum or plasma microRNAs may serve as a comple-
mentary source of robust biomarkers for tuberculosis and other
infectious diseases (68–72). Notwithstanding this, further work
using large PBL sample panels from additional animals infected
with M. bovis and other microbial pathogens will be required
to identify and validate robust M. bovis-specific transcriptional
signatures of infection.
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